Research and development commitments in an integrated plasma collection and plasma fractionation environment

Authors
Citation
M. Radosevich, Research and development commitments in an integrated plasma collection and plasma fractionation environment, SEM THROMB, 24(2), 1998, pp. 157-161
Citations number
24
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
SEMINARS IN THROMBOSIS AND HEMOSTASIS
ISSN journal
00946176 → ACNP
Volume
24
Issue
2
Year of publication
1998
Pages
157 - 161
Database
ISI
SICI code
0094-6176(1998)24:2<157:RADCIA>2.0.ZU;2-7
Abstract
Plasma fractionation has emerged as one of the most scientifically demandin g fields in the biopharmaceutical area. Producing safe plasma derivatives i mplies the development, use, and proper understanding of sensitive testing technologies to detect infection markers in starting plasma. It also requir es the implementation of carefully selected, nondenaturing, efficient plasm a protein purification and viral reduction technologies that do not alter t he physiological functions and clinical potential of plasma proteins. Succe ss in this field can be achieved only by a strong commitment to sustain con stant research and development of projects targeting the production of safe r and innovative plasma products.